These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9101000)

  • 1. Extent and variation of omeprazole prescribing in an elderly population of Ontario.
    McBride JE; Pater JL; Dorland JL; Lam YM
    Ann Pharmacother; 1997 Apr; 31(4):411-6. PubMed ID: 9101000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.
    Harris BN; West DS; Johnson J; Hong SH; Stowe CD
    J Manag Care Pharm; 2004; 10(5):449-55. PubMed ID: 15369428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton pump inhibitors: a study of GPs' prescribing.
    Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
    Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
    Kumana CR; Ching TY; Cheung E; Kong Y; Kou M; Chan CK; Chu KM; Seto WH; Lam SK
    Clin Pharmacol Ther; 1998 Nov; 64(5):569-74. PubMed ID: 9834050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
    Dhippayom T; Walker R
    Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appropriateness of omeprazole prescribing in Quebec's senior population.
    Grégoire JP; Moisan J; Chabot I; Gaudet M
    Can J Gastroenterol; 2000 Sep; 14(8):676-80. PubMed ID: 11185532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentially inappropriate prescribing in Canada relative to the US.
    Rochon PA; Lane CJ; Bronskill SE; Sykora K; Anderson GM; Mamdani MM; Gurwitz JH; Dhalla IA
    Drugs Aging; 2004; 21(14):939-47. PubMed ID: 15554752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database.
    Levy AR; O'Brien BJ; Sellors C; Grootendorst P; Willison D
    Can J Clin Pharmacol; 2003; 10(2):67-71. PubMed ID: 12879144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How complete are drug history profiles that are based on public drug benefit claims?
    Paterson JM; Suleiman A; Hux JE; Bell C
    Can J Clin Pharmacol; 2008; 15(1):e108-16. PubMed ID: 18283220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescribing of antacids and ulcer-healing drugs in primary care in the north of England.
    Roberts SJ; Bateman DN
    Aliment Pharmacol Ther; 1995 Apr; 9(2):137-43. PubMed ID: 7605853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
    Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
    Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents.
    Lane CJ; Bronskill SE; Sykora K; Dhalla IA; Anderson GM; Mamdani MM; Gill SS; Gurwitz JH; Rochon PA
    J Am Geriatr Soc; 2004 Jun; 52(6):861-6. PubMed ID: 15161447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton-pump inhibitor utilization associated with the change to nonpreferred formulary status for esomeprazole in the TRICARE formulary.
    Linton A; Bacon T; Peterson M
    J Manag Care Pharm; 2009; 15(1):42-54. PubMed ID: 19125549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coprescribing of nonsteroidal anti-inflammatory drugs and cytoprotective and antiulcer drugs in Nova Scotia's senior population.
    Kephart G; Sketris I; Smith M; Maheu A; Brown M
    Clin Ther; 1995; 17(6):1159-73. PubMed ID: 8750407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Omeprazole. Antiulcer and gastric anti-secretory agent: one of the most prescribed drugs in France].
    Taeron C
    Rev Infirm; 2002 Oct; (84):49-50. PubMed ID: 12432644
    [No Abstract]   [Full Text] [Related]  

  • 18. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.
    Tamblyn R; Huang A; Perreault R; Jacques A; Roy D; Hanley J; McLeod P; Laprise R
    CMAJ; 2003 Sep; 169(6):549-56. PubMed ID: 12975221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The Netherlands.
    van Hout BA; Klok RM; Brouwers JR; Postma MJ
    Clin Ther; 2003 Feb; 25(2):635-46. PubMed ID: 12749518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate prescribing before and after nursing home admission.
    Dhalla IA; Anderson GM; Mamdani MM; Bronskill SE; Sykora K; Rochon PA
    J Am Geriatr Soc; 2002 Jun; 50(6):995-1000. PubMed ID: 12110057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.